Drostanolone Enanthate 200 mg

Drostanolone Enanthate 200 mg/ml — Swiss Remedies

• Brand: Swiss Remedies
• Category: Injectable AAS · DHT-derived anabolic steroid
• Content: 200 mg/ml drostanolone enanthate
• Packaging: 10 1 ml ampoules (total 2,000 mg)
• Origin: Switzerland
• Research Notice: Laboratory, forensic or educational research only. Not for human or veterinary use.

Product Overview

Drostanolone Enanthate is the long-acting ester of drostanolone — a

dihydrotestosterone (DHT)–derived anabolic steroid that does not aromatise to estrogen.

The enanthate ester increases lipophilicity and produces a sustained intramuscular depot release.

Historically, drostanolone was clinically investigated for advanced breast cancer due to its

androgenic and anti-estrogenic effects. Today, it is globally classified as a

performance-enhancing drug and appears on the WADA S1 list of prohibited anabolic agents.

This listing is provided exclusively for research on androgen receptor signalling, AAS metabolism,

toxicology and anti-doping detection methods.

Key Research Highlights

DHT-derived structure:

Non-aromatisable no conversion to estrogen, supporting research into pure androgenic signalling.

Strong AR agonist:

Binds the androgen receptor with high affinity regulates protein synthesis, nitrogen balance and anabolic pathways.

Enanthate ester behaviour:

Prolonged release from injection site suitable for long-acting androgen exposure models.

Oncology context:

Investigated historically for anti-estrogenic activity in breast cancer research.

Doping-relevance:

Prohibited anabolic agent (WADA S1); extensively studied in anti-doping detection science.

Mechanism of Action

• AR activation: Promotes transcription of genes for protein synthesis & nitrogen retention
• DHT-based profile: No aromatisation research into androgen-only signalling effects
• Depot release: Enanthate ester prolongs systemic nandrogen exposure
• Anti-estrogenic action in breast tissue: Historical oncology interest

Technical Specification Table

Field

Data

Active substance

Drostanolone (as Drostanolone Enanthate)

Chemical class

Anabolic-androgenic steroid · 5-reduced DHT derivative

Molecular formula

C20H32O2 (drostanolone base)

Molecular weight

304.5 g/mol (base)

Aromatisation

Does not aromatise to estrogen

Historical medical use

Advanced breast cancer (discontinued in many regions)

Doping status

Prohibited anabolic agent (WADA S1)

Route (research context)

Intramuscular injection (oil-based)

Legal Status

Controlled substance in many jurisdictions

Research Applications

• Androgen receptor signalling & transcription studies
• Comparative anabolic vs. androgenic profiling
• AAS metabolism & toxicology studies
• Anti-doping detection R&D (urine/blood identification)
• Comparison with testosterone, nandrolone & other AAS

Side Effects / Risks (Class-Based)

• Androgenic effects: acne, oily skin, accelerated hair loss
• Endocrine suppression: reduced testosterone, fertility impact
• Virilisation in female subjects (deepened voice, hair changes)
• Changes in HDL/LDL and cardiovascular strain
• Potential hepatic stress at high or prolonged exposure
• Mood changes or irritability noted in AAS misuse reports

Compliance & Legal Notice

Drostanolone and its esters are banned at all times in sport by WADA and national anti-doping bodies.

Controlled substance in many jurisdictions; unauthorised possession may be illegal.

FOR RESEARCH USE ONLY. Not for human or animal use. Not a dietary supplement or bodybuilding product.

Researchers must follow institutional SOPs and regulatory requirements for handling anabolic steroids.